China Biologic Products (CBPO)
Add to Watchlists Create an AlertChina Biologic Products EBITDA TTM
China Biologic Products EBITDA TTM Chart
View EBITDA TTM for CBPO.
Start Your YCharts Pro Gold Membership.
China Biologic Products Historical EBITDA TTM Data
Pro Data ExportThere is no data for the selected date range.
About EBITDA (TTM)
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization. EBITDA (TTM) is the sum of the last four quarters of EBITDA.
Investors often use EBITDA as a starting point for discounted cash flow analysis or to observe the performance of a business separately from its capital structure (debt vs equity financing structure).
Though EBITDA does form an excellent basis for cash flow analysis, some investors argue that it is a misleading measure since depreciation expenses are a real cost - old property, plant and equipment must eventually be replaced if a business plans to continue operations using those assets.
Learn More
View EBITDA TTM for CBPO.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
CBPO EBITDA TTM Benchmarks
| Companies | |
|---|---|
| Acorda Therapeutics | Go Pro |
| Vanda Pharmaceuticals | Go Pro |
| Theravance | Go Pro |
CBPO EBITDA TTM Rankings
| Overall |
75th percentile 1928 of 8009 |
| Sector |
80th percentile 132 of 687 in Healthcare |
| Industry |
93rd percentile 16 of 248 in Biotechnology |